Abstracts tagged "rheumatoid arthritis (RA) and anti-CCP antibodies"

Abstract Number: 191 • 2019 ACR/ARP Annual Meeting
Associations of Self-Reported Inhalant Exposures with Autoantibodies and Disease Severity in U.S. Veterans with Rheumatoid Arthritis
Ariadne Ebel¹, Jill Poole ², Geoffrey Thiele ³, Joshua Baker ⁴, Grant Cannon ⁵, Angelo Gaffo ⁶, Gail Kerr ⁷, Andreas Reimold ⁸, John S. Richards ⁹, Pescale Schwab ¹⁰, Namrata Singh ¹¹, Dana Ascherman ¹², Ted Mikuls ³ and Bryant England ¹³, ¹University of Nebraska, Omaha, NE, ²University of Nebraska Medical Center, Omaha, NE, ³VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, NE, ⁴University of Pennsylvania, Philadelphia, PA, ⁵Salt Lake City VA Medical Center and Univeristy of Utah, Salt Lake City, UT, ⁶University of Alabama at Birmingham, Birmingham, AL, ⁷Washington DC VA Medical Center, Georgetown and Howard Universities, Washington DC, DC, ⁸UT Southwestern Medical Center, Dallas, ⁹VA Pittsburgh Healthcare System, Pittsburgh, PA, ¹⁰VA Portland Healthcare System, Porland, ¹¹University of Iowa, Iowa City, ¹²University of Pittsburgh, Pittsburgh, ¹³VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha
Background/Purpose: Cigarette smoke is a known inhalant exposure that contributes substantially to the risk and severity of rheumatoid arthritis (RA). Less is known about the…
Abstract Number: 2229 • 2019 ACR/ARP Annual Meeting
Differences in Fracture Risk Assessment (FRAX) and Osteoporosis Treatment Cutoffs with and Without Bone Mineral Density Are Greater in Anti-Cyclic Citrullinated Peptide Positive Rheumatoid Arthritis
Katherine Wysham¹, Jonathan Graf ², Mary Margaretten ², Laura Trupin ², James Andrews ³, Dolores Shoback ² and Patricia Katz ², ¹Veterans Health Administration Puget Sound, Seattle WA, Seattle, ²University of California, San Francisco, San Francisco, CA, ³University of Washington, Seattle, WA
Background/Purpose: FRAX (Fracture Risk Assessment Tool) is the most commonly used tool to estimate 10-year fracture risk. FRAX estimates are performed with and without bone…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].